Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver.
about
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondBiochemical Genetic Pathways that Modulate Aging in Multiple SpeciesThe effects of graded levels of calorie restriction: IX. Global metabolomic screen reveals modulation of carnitines, sphingolipids and bile acids in the liver of C57BL/6 mice.Short-term rapamycin treatment in mice has few effects on the transcriptome of white adipose tissue compared to dietary restriction.Longevity, aging and rapamycin.Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver.Diminished mTOR signaling: a common mode of action for endocrine longevity factors.Lifespan modulation in mice and the confounding effects of genetic background.Gene expression in the liver of female, but not male mice treated with rapamycin resembles changes observed under dietary restriction.Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effectsComparative idiosyncrasies in life extension by reduced mTOR signalling and its distinctiveness from dietary restrictionAberrant mTOR activation in senescence and aging: A mitochondrial stress response?Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome.Dietary restriction reduces blood lipids and ameliorates liver function of mice with hyperlipidemia.Caloric Restriction Engages Hepatic RNA Processing Mechanisms in Rhesus Monkeys.Caloric Restriction and Rapamycin Differentially Alter Energy Metabolism in Yeast.Tissue-specific transcriptome profiling of Drosophila reveals roles for GATA transcription factors in longevity by dietary restriction.
P2860
Q26751462-2CD74675-4361-491C-B1AC-F5E14F06757EQ26777407-44C237AA-B1C5-452F-905F-EBBB028A5D07Q33638897-ED56B1F2-5375-48E7-B07C-3F446C239378Q34205373-4AC72039-AAB2-4508-B9A6-6F9D43C1CDEDQ34396541-64DA0EE8-60F7-44D8-A17E-3D637A6C94D8Q34416589-44A7F28D-A300-4797-8086-11B205382D29Q34462362-5B850F33-6DA4-4436-926C-5741922EFEA9Q34642886-60148FE4-F2E2-4AC5-B64B-A11ECBDED0B0Q35661590-0FA57815-16CA-460B-BDB6-EF8C2901CE45Q35935141-79BCAB7C-BFB1-4CDC-9DB5-8E57292C3645Q37066990-8E2F661E-36D7-4828-A06B-AB360F0AD176Q38275627-FD2A56F4-8D78-4B76-896C-BABEC8DDF089Q50426370-F01D18FE-A1F7-444F-9D60-A068A96812AFQ50454502-D3B4B1FE-CA9D-4F99-AAC6-C55B7614D75CQ51765154-0C078246-A3CB-49D4-B994-D030E58C72DBQ51833795-F3E2E585-1CAC-4265-B9FE-05A1E5A03E40Q52804659-66C712A9-1D09-4B27-BEB6-DC5513B39694
P2860
Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@ast
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@en
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@nl
type
label
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@ast
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@en
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@nl
prefLabel
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@ast
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@en
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@nl
P2093
P2860
P356
P1433
P1476
Combined treatment of rapamyci ...... ptome and metabolome of liver.
@en
P2093
Arlan Richardson
Jonathan Gelfond
Kevin G Becker
Mark Doderer
Martin Javors
Viviana I Pérez
William H Wood
Yidong Chen
Yiqiang Zhang
Yongqing Zhang
P2860
P304
P356
10.1111/ACEL.12175
P577
2013-12-05T00:00:00Z